Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Endocrinology and Metabolic Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Lancet Diabetes Endocrinol. 2023 Apr;11(4):261-281. doi: 10.1016/S2213-8587(23)00001-3. Epub 2023 Feb 24.
Tackling the mechanisms underlying ageing is desirable to help to extend the duration and improve the quality of life. Life extension has been achieved in animal models by suppressing the growth hormone-insulin-like growth factor 1 (IGF-1) axis and also via dietary restriction. Metformin has become the focus of increased interest as a possible anti-ageing drug. There is some overlap in the postulated mechanisms of how these three approaches could produce anti-ageing effects, with convergence on common downstream pathways. In this Review, we draw on evidence from both animal models and human studies to assess the effects of suppression of the growth hormone-IGF-1 axis, dietary restriction, and metformin on ageing.
解决衰老的潜在机制是可取的,有助于延长寿命并提高生活质量。通过抑制生长激素-胰岛素样生长因子 1 (IGF-1) 轴以及饮食限制,已经在动物模型中实现了寿命延长。二甲双胍作为一种潜在的抗衰老药物,引起了越来越多的关注。这三种方法产生抗衰老作用的推测机制有一些重叠之处,它们在共同的下游途径上收敛。在这篇综述中,我们借鉴了来自动物模型和人类研究的证据,评估了抑制生长激素-IGF-1 轴、饮食限制和二甲双胍对衰老的影响。